Maternal Fetal Device Performance Twins

Launched by GE HEALTHCARE · Feb 17, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new device designed to monitor the health of mothers and their twin babies during pregnancy. The goal is to see how well this new monitoring device works by comparing it to an existing ultrasound device. Both devices will help healthcare professionals track important health information about the mother and her twins, which can aid in making better decisions for their care.

To participate in this study, women must be at least 18 years old, have a twin pregnancy, and be at least 30 weeks along in their pregnancy. They also need to be able to understand and agree to the study. If you join, you can expect to have your babies' heart rates monitored using both the new device and a standard ultrasound, helping researchers gather important data on how well the new device performs. This study is currently looking for participants, and your involvement could help improve care for future pregnancies with twins.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Able and willing to provide written informed consent.
• • 2. Twin pregnancy.
• • 3. Aged 18+.
• • 4. Greater than or equal to 30 0/7 weeks gestation.
• • 5. Patient has none of the exclusion criteria.
• Exclusion Criteria:
• • 1. Non-twin pregnancy.
• • 2. Involvement in another clinical trial currently or previously in this pregnancy that, in the investigator's opinion, would affect the conduct of this study.
• • 3. Medical or obstetric problem that in investigator's opinion would make the patient incapable of taking part in the study.
• • 4. Inability to understand the consent information due to medical illness, diminished intellectual capacity, or insurmountable language barrier.